Generic Name and Formulations:
Methenamine 118mg, sodium phosphate monobasic 40.8mg, phenyl salicylate 36mg, methylene blue 10mg, hyoscyamine sulfate 0.12mg; caps.
Mission Pharmacal Company
Indications for URIBEL:
Treatment of symptoms of irritative voiding. Relief of local symptoms due to lower UTIs or diagnostic procedures.
1 cap 4 times daily.
≤6yrs: not recommended. >6yrs: individualize dose.
Cardiac disease. GI or GU obstruction. Glaucoma. Myasthenia gravis.
Discontinue if rapid pulse, dizziness, or blurred vision occurs. Gastric ulcers. Maintain acid urine and adequate hydration. Elderly. Pregnancy (Cat.C). Nursing mothers.
Allow at least 2 hours after ketoconazole. May be potentiated by antimuscarinics, MAOIs. Reduced intestinal motility with antimyasthenics. Increased risk of severe constipation with opioids. May be antagonized by thiazide diuretics, urinary alkalinizers. Separate dosing of antacids, antidiarrheals by 1 hour. May reduce absorption of other drugs. Sulfonamides precipitate with formaldehyde in urine; avoid concomitant use.
Urinary tract analgesic/antispasmodic/antiseptic.
Rapid pulse, flushing, blurred vision, dizziness, shortness of breath, acute urinary retention, difficult micturition, dry mouth, nausea, vomiting, discolored urine/feces.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)